March 12, 2010

The boxed warning for Plavix’s label alerts doctors that genetic tests are available to establish patients’ CYP2C19 status. However, the FDA leaves it up to physicians to decide whether to wait for genetic testing results or put patients on an alternative treatment.

Article found on Genome Web.  Full-text access for premium subscribers only.
Get immediate access with a three-month trial for $95.

DNAistheWay.net

Related posts:

  1. Celebrity genomics without the Y chromosome: Glenn Close has her genome sequenced.
  2. Willful ignorance is not an effective argument against personal genomics: a response to “When DNA means do not ask”.
  3. Genome work ushers in new genetic era
  4. When DNA means do not ask
  5. Learn How You’ll Die For Only $68,000